Anti-PL 12 and pulmonary fibrosis in a patient ten years after silica/silicate dust exposure.
W
W
Osterode
H
H
Rüdiger
W
W
Graninger
D H
DH
Petzl
K
K
Rappersberger
G
G
Dekan
A
A
Weihs
W
W
Graninger
D000328:Adult; D000412:Alanine-tRNA Ligase / Q000276:immunology*; D018771:Arthralgia / Q000139:chemically induced; D001323:Autoantibodies / Q000032:analysis*; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D018908:Muscle Weakness / Q000139:chemically induced; D009784:Occupational Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D016273:Occupational Exposure / Q000009:adverse effects*; D011239:Prednisolone / Q000627:therapeutic use; D011658:Pulmonary Fibrosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D017640:Silicates / Q000009:adverse effects*; D012822:Silicon Dioxide / Q000009:adverse effects*; D012829:Silicosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D014057:Tomography, X-Ray Computed
D001323:Autoantibodies; D017640:Silicates; D012822:Silicon Dioxide; D011239:Prednisolone; D000412:Alanine-tRNA Ligase; D008727:Methotrexate